{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:43:31Z","timestamp":1768031011178,"version":"3.49.0"},"reference-count":26,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T00:00:00Z","timestamp":1247011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> The use of proton pump inhibitors (PPIs) is extensive. While the incidence of new treatments remains stable, the prevalence of long\u2010term treatment is rising. Studies have shown that up to 70% of patients on chronic acid suppression lack a verified indication for treatment.<\/jats:p><jats:p><jats:bold>Aims\u2002<\/jats:bold> To investigate primary care patient characteristics associated with long\u2010term use of PPIs.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> A cross\u2010sectional analysis of 42\u2003634 patients registered with 22 general practitioners was performed. Patients with prescriptions of \u2265120\u2003tablets\/year were defined as long\u2010term users. A survey of a subgroup of patients without verified indication was performed.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> In all, 901 (2.1%) patients were long\u2010term treated. Verified indications for treatment were identified for 247\/901 (27%). An upper GI endoscopy had been performed in 418 patients (46%). Of the 194\/654 without verified indication who participated in the survey, 71% reported heartburn\/acid regurgitation as the reason for therapy. On\u2010demand therapy was reported by 43\/194 (22%) and previous attempts to withdraw by 119\/194 (61%).<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> The prevalence of PPI long\u2010term treatment among primary care patients is 2.1%. The main reason for treatment is reflux symptoms or verified GERD. Rationalization of use of PPIs is possible as daily treatment without attempts to discontinue is frequently observed.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2009.04092.x","type":"journal-article","created":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T00:17:22Z","timestamp":1247185042000},"page":"725-732","source":"Crossref","is-referenced-by-count":31,"title":["Clinical trial: long\u2010term use of proton pump inhibitors in primary care patients \u2013 a cross sectional analysis of 901 patients"],"prefix":"10.1111","volume":"30","author":[{"given":"C.","family":"REIMER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"BYTZER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,9,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02120.x"},{"key":"e_1_2_6_3_2","volume-title":"NICE clinical guideline 17. Dyspepsia \u2010 management of dyspepsia in adults in primary care","author":"National Institute for Clinical Excellence","year":"2004"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.00225.x"},{"key":"e_1_2_6_5_2","volume-title":"2000\/022 NICE Issues Guidance on Proton Pump Inhibitors for Dyspepsia","author":"National Institute for Clinical Excellence","year":"2000"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07186.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02289.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00524.x"},{"key":"e_1_2_6_9_2","first-page":"451","article-title":"Long\u2010term prescribing of proton pump inhibitors in general practice","volume":"49","author":"Hungin AP","year":"1999","journal-title":"Br J Gen Pract"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00943.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01999.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00410.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000192173.00498.ba"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01928.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00374.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.3109\/13814780309160421"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03084.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1053\/bega.2001.0190"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.01.004"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.5.649"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.03.058"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02531.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604183341603"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.101634"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33019"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00673.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199801000-00006"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2009.04092.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2009.04092.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:14:07Z","timestamp":1697228047000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2009.04092.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,3]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1365-2036.2009.04092.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04092.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,3]]}}}